Journal
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION
Volume 69, Issue 8, Pages 858-864Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/00365510903348677
Keywords
Adipokines; pediatrics; inflammation; insulin resistance
Categories
Funding
- Norwegian Foundation for Health and Rehabilitation
- Norwegian Women's Public Health Association
- Ullevaal University Hospital Scientific Advisory Committee
- South-Eastern Norway Regional Health Authority
- Norwegian Ministry of health and care services
- Norwegian Directorate of Health
Ask authors/readers for more resources
Objective: Adipokines have been implicated in the pathogenesis of metabolic syndrome (MetS) and insulin resistance. We investigated the association between these conditions and serum levels of visfatin, adiponectin and leptin. Material and methods: 175 overweight and obese boys and girls aged 3-17 years. MetS was defined as presence of at least three of the following: triglycerides >= 1.24 mmol/L, high-density lipoprotein cholesterol <= 1.03 mmol/L, fasting glucose >= 6.1 mmol/L, elevated waist circumference and systolic or diastolic blood pressure >= 90th percentile. Results: After adjustment for age and gender visfatin levels were significantly higher (median 19.0 [ 25th, 75th percentiles 11.9, 37.1] vs. 15.2 [ 11.6, 21.1] ng/ml; p(adjusted) = 0.02) in subjects with MetS (n = 41) compared to subjects without (n = 134). There were no significant differences in adiponectin or leptin levels between the two groups after adjustment for age and gender. Visfatin levels increased proportionally with number of MetS components (beta = 0.16, 95% CI 0.04, 0.28; p(adjusted) = 0.01), and adiponectin levels decreased proportionally with number of components (beta = -0.11, 95% CI -0.18, -0.04; p(adjusted) = 0.002). Leptin levels were not related to number of components of MetS. Unlike visfatin, both adiponectin (beta = -0.24, 95% CI -0.33, -0.15; p(adjusted) < 0.001) and leptin (beta = 0.14, 95% CI 0.01, 0.28; p(adjusted) = 0.03) were associated with insulin resistance. Conclusion: The elevation of visfatin observed in children and adolescents with MetS was proportionate to number of components of MetS but was not associated with insulin resistance. The increase in visfatin may contribute to low-grade systemic inflammation associated with MetS.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available